Pediatrix Medical Group, Inc. (MD) — Analyst outlook / Analyst consensus target is. Based on 33 analyst ratings, the consensus is bullish — 14 Buy, 17 Hold, 2 Sell.
The consensus price target is $20.67 (low: $19.00, high: $22.00), representing a downside of 8.6% from the current price $22.61.
Analysts estimate Earnings Per Share (EPS) of $1.35 and revenue of $2.00B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $-1.19 vs est $1.35 (missed -188.2%). 2025: actual $1.94 vs est $2.08 (missed -6.9%). Analyst accuracy: 0%.
MD Stock — 12-Month Price Forecast
$20.67
▼ -8.58% Downside
Average Price Target
Based on 33 Wall Street analysts offering 12-month price targets for Pediatrix Medical Group, Inc., the average price target is $20.67, with a high forecast of $22.00, and a low forecast of $19.00.
The average price target represents a -8.58% change from the last price of $22.61.
Highest Price Target
$22.00
Average Price Target
$20.67
Lowest Price Target
$19.00
MD Analyst Ratings
Hold
Based on 33 analysts giving stock ratings to Pediatrix Medical Group, Inc. in the past 3 months
EPS Estimates — MD
0%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual –$1.19
vs Est $1.35
▼ 213.4% off
2025
Actual $1.94
vs Est $2.08
▼ 7.4% off
Profitability Outlook
Company has mixed profitability — some years profitable, some at a loss. EPS trend is improving.
Revenue Estimates — MD
99%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $2.013B
vs Est $1.997B
▲ 0.8% off
2025
Actual $1.914B
vs Est $1.905B
▲ 0.5% off
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
